Showing results (191-200 of 212) with videos related to

Sort By:
Pageof 22
The New England Journal of Medicine|February 12, 2011
Apixaban in patients with atrial fibrillationStuart J Connolly, John Eikelboom, Campbell Joyner, et al.
The New England Journal of Medicine|April 5, 2016
Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular DiseaseEva M Lonn, Jackie Bosch, Patricio López-Jaramillo, et al.
Circulation|September 27, 2019
Antithrombotic Therapy in Patients With Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or With Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights From the AUGUSTUS TrialStephan Windecker, Renato D Lopes, Tyler Massaro, et al.
The New England Journal of Medicine|August 30, 2011
Apixaban versus warfarin in patients with atrial fibrillationChristopher B Granger, John H Alexander, John J V McMurray, et al.
JACC. Advances|April 27, 2025
Impact of Apolipoprotein A-I Infusions on Cardiovascular Events Post-MI by Neutrophil-Lymphocyte Ratio and LDL-Cholesterol LevelsSem A O F Rikken, C Michael Gibson, M Cecilia Bahit, et al.
Lancet (London, England)|November 15, 2017
Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trialSonia S Anand, Jackie Bosch, John W Eikelboom, et al.
European Journal of Heart Failure|November 10, 2025
Adherence to guideline-directed medical treatments in heart failure. A scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Working Group on Cardiovascular PharmacotherapyGianluigi Savarese, Felix Lindberg, Antonio Cannata, et al.
European Heart Journal|June 3, 2021
The effect of intravenous ferric carboxymaltose on health-related quality of life in iron-deficient patients with acute heart failure: the results of the AFFIRM-AHF studyEwa A Jankowska, Bridget-Anne Kirwan, Mikhail Kosiborod, et al.
Lancet (London, England)|November 16, 2020
Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trialPiotr Ponikowski, Bridget-Anne Kirwan, Stefan D Anker, et al.
The New England Journal of Medicine|April 8, 2024
Apolipoprotein A1 Infusions and Cardiovascular Outcomes after Acute Myocardial InfarctionC Michael Gibson, Danielle Duffy, Serge Korjian, et al.
Pageof 22